Can-Fite BioPharma's total assets for Q4 2024 were $9.12M, a decrease of 0.00% from the previous quarter. CANF total liabilities were $3.68M for the fiscal quarter, a 0.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.